Skip to main content
Article thumbnail
Location of Repository

Manipulation of NKG2D Ligands by Cytomegaloviruses: Impact on Innate and Adaptive Immune Response

By Irena Slavuljica, Astrid Krmpotić and Stipan Jonjić

Abstract

NKG2D is a potent activating receptor expressed on NK cells, NKT cells, γδ T cells, and CD8 T cells. NKG2D recognizes cell surface molecules structurally related to MHC class I proteins induced by infection or other type of cellular stress. The engagement of NKG2D leads to NK cell cytotoxicity and cytokine secretion or to a co-stimulation of CD8 T cells. Both human and mouse cytomegalovirus (CMV) have evolved numerous mechanisms to evade NKG2D-mediated immune response. This review describes the mechanisms used by CMV to inhibit NKG2D ligand expression and the recent advances in exploiting the NKG2D recognition pathway for mounting efficient and long-lasting immune response

Topics: Immunology
Publisher: Frontiers Research Foundation
OAI identifier: oai:pubmedcentral.nih.gov:3342069
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2002). A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3.
    2. (2003). A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    3. (2008). A role for NKG2D in NK cell-mediated resistance to poxvirus disease.
    4. (2004). A structural basis for the association of DAP12 with mouse, but not human,
    5. (2005). Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.
    6. (2002). adapterstotriggerNKcellactivation and costimulation.
    7. (2005). Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependentNKcelllysisand tumor rejection.
    8. (2011). Article 85 | 9Slavuljica et al. Cytomegalovirus regulation of NKG2D ligands
    9. (1996). Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium.
    10. (2004). Cell surface organization of stress-inducible proteins ULBP andMICAthatstimulatehumanNK cells and T cells via NKG2D.
    11. (2004). Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.
    12. (2009). Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin.
    13. (2005). Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differencesbetweenNKG2DandCD28 costimulation.
    14. (2010). Critical role for the chemokine receptor CXCR6 inNKcell-mediatedantigen-specific memoryofhaptensandviruses.Nat.
    15. (2003). Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.
    16. (2010). Cross-presentation of a spread-defective MCMV is sufficient to prime the majority of virus-specific CD8+ Tcells.
    17. (2002). Cutting edge: murine UL16-binding protein-like transcript1:anewlydescribedtranscript encoding a high-affinity ligand for murine NKG2D.
    18. (2004). Cutting edge: toll-like receptor signaling in macrophagesinducesligandsforthe NKG2D receptor.
    19. (2004). Cytokine and contact-dependent activation of natural killer cells by influenza A or sendai virusinfected macrophages.
    20. (2011). Cytomegalovirus regulation of NKG2D ligands
    21. (2001). Cytomegalovirus regulation of NKG2D ligands by NKG2D via engagement by MIC induced on virus-infected cells.
    22. (2008). Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PDL1/PD-1 pathway.
    23. (2003). Dendritic cell responses to earlymurinecytomegalovirusinfection:subsetfunctionalspecialization and differential regulation by interferon alpha/beta.
    24. (2009). Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus.
    25. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
    26. (1991). DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells.
    27. (2006). Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.
    28. (2001). Ectopic expression of retinoic acid early inducible1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo.
    29. (2003). Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
    30. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ Tcells.
    31. (2005). Evolution of diverse antiviral CD8+ Tcell populations after murine cytomegalovirus infection.Eur.J.Immunol.35,1113–1123.
    32. (2011). Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation.
    33. (2003). Functional interactions between dendritic cells and NK cells during viral infection.
    34. (2006). gene expression.
    35. (1996). Genomic structures and characterization of Rae1 family members encoding GPIanchored cell surface proteins and expressed predominantly in embryonic mouse brain.
    36. H.,andLanier,L.L.(2000).Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.
    37. H.(1997).Amousecytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cisGolgi compartments.
    38. (1998). Hierarchical and redundant lymphocytesubsetcontrolprecludes cytomegalovirus replication during latent infection.
    39. (2007). HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts.
    40. (2009). HIV-1 Vpr triggersnaturalkillercell-mediatedlysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog.
    41. (2007). Host immune system gene targeting by a viral miRNA.
    42. (2003). Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.
    43. (2008). Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D.
    44. (1994). Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor.
    45. (2004). Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells.
    46. Induction of NKG2D ligands on humandendriticcellsbyTLRligand stimulation and RNA virus infection.
    47. (2001). Infection of dendritic cells by murine cytomegalovirus induces functional paralysis.
    48. (2002). Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributionsfromdirectprimingandcrosspriming in induction of vaccinia virus-specific CD8(+) T cells.
    49. (2008). Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
    50. (2005). interference with antigen presentation to CD8+ Tcells: lessons from cytomegalovirus.Viral Immunol.
    51. (2002). Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo.
    52. (2009). Interferongamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediatedcytolysisof MHC class I-deficient melanoma by natural killer cells.
    53. (2001). Interferons alpha and beta as immune regulators – a new look.
    54. (2003). Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirusUL16glycoprotein.
    55. (1994). Isolation and characterization of retinoic acidinducible cDNA clones in F9 cells: one of the early inducible clones encodes a novel protein sharing several highly homologous regions with a Drosophila polyhomeoticprotein.Differentiation57,
    56. (2011). Krmpoti´ cA and Jonji´ c S
    57. L.(2009).Adaptiveimmunefeatures of natural killer cells.
    58. Lemmermann,N.A.,Bohm,V.,Holtappels,R.,andReddehase,M.J.(2011). In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models. Virus Res.
    59. (2000). Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.
    60. (2003). Memory inflation: continuousaccumulationofantiviralCD8+ Tcells over time.
    61. (2008). Modulation of natural killer cells by human cytomegalovirus.
    62. (2008). Murine cytomegalovirus regulation of NKG2D ligands.
    63. (2008). Murine model of cytomegalovirus latency and reactivation.
    64. (2007). Natural killer cells promote early CD8 T cell responses against cytomegalovirus.
    65. (2005). NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.
    66. (2005). NKG2D is a costimulatory receptor for human naive CD8+ Tcells.
    67. (2009). NKG2D ligand MICA isretainedinthecis-Golgiapparatus by human cytomegalovirus protein UL142.
    68. (2008). NKG2D receptor signaling enhances cytolytic activity by virusspecific CD8+ Tcells: evidence for a protective role in virus-induced encephalitis.
    69. (2001). NKG2D receptors inducedbyIL-15costimulateCD28-negative effector CTL in the tissue microenvironment.J.Immunol.167,
    70. (2003). NKG2D-mediated natural killer cell protection against cytomegalovirusisimpairedbyviral gp40 modulation of retinoic acid early inducible 1 gene molecules.
    71. (2007). NKp46 and NKG2Drecognitionofinfecteddendritic cells is necessary for NK cell activation in the human response to influenza infection.J.
    72. (2005). Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus.
    73. (2003). Pathogenesisof murinecytomegalovirusinfection.
    74. Phillips,J.H.,Lanier,L.L.,andSpies, T.(1999).Activationof NKcellsand T cells by NKG2D, a receptor for stress-inducible MICA.
    75. (2009). Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in northeastern Thais.
    76. (2009). Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress.
    77. (2007). Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D.
    78. (2001). Rae1andH60ligandsoftheNKG2D receptor stimulate tumour immunity.
    79. (2007). Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses.
    80. (2010). Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.
    81. (2001). Regulationofcutaneousmalignancy by gammadelta T cells.
    82. (2004). Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ Tcells.
    83. (2002). Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D.
    84. (2005). Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.
    85. (2011). Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
    86. (2001). Strategies for target cell recognition by natural killer cells.
    87. (2010). Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands.
    88. (2006). TGF-beta and metalloproteinases differentially suppress NKG2Dligandsurfaceexpressionon malignant glioma cells.
    89. (1994). The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease.
    90. (2004). The cytomegalovirus m155 gene product subverts naturalkillercellantiviralprotectionby disruption of H60-NKG2D interactions.
    91. (1999). The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T c e l lc o n t r o li nv i v o .J.
    92. (2000). The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules.
    93. (1998). The molecular and functional characterization of a dominant minor H antigen,
    94. (2011). The mouse cytomegalovirus glycoprotein m155 inhibits CD40 expression and restricts CD4 T cell responses.
    95. (2002). The role of the NKG2D immunoreceptor in immune cell activation and natural killing.
    96. (2002). Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype.
    97. (2004). Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D.
    98. Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D.
    99. (2005). Type I interferons (alpha/beta) in immunity and autoimmunity.
    100. (2009). ULBP6/RAET1L is an additional human NKG2D ligand.
    101. (2001). ULBPs,
    102. (2007). Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murinecytomegalovirusinfection.J.
    103. (2006). Viral interference with B7-1 costimulation:a new role for murine cytomegalovirus fc receptor-1.
    104. (1998). Virus attenuation after deletion of the c y t o m e g a l o v i r u sF cr e c e p t o rg e n ei s not due to antibody control.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.